On Wednesday, Novavax (NASDAQ: NVAX), the U.S.-based vaccine maker, said it would sell its manufacturing facility in the Czech Republic […]
Novavax to Sell Czech Manufacturing Unit to Novo Nordisk for $200 Million Read More »
On Tuesday, Novavax (NASDAQ: NVAX) cut its annual revenue forecast, citing lower-than-expected sales of its COVID-19 vaccine, ahead of handing
On Tuesday, Novavax (NASDAQ: NVAX) said it has entered into a termination and settlement agreement with the UK Health Security
Novavax and UK Officially Terminate COVID-19 Vaccine Supply Contract Read More »
The U.S. Food and Drug Administration has put on hold a trial of Novavax’s (NASDAQ: NVAX) COVID-influenza and its standalone
Novavax (NASDAQ: NVAX) Stock Tumbles After FDA Pauses COVID-Flu Vaccine Trial Read More »
The European Commission authorized Novavax’s (NASDAQ: NVAX) updated COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region, the
On Friday, the U.S. Food and Drug Administration granted emergency use authorization for an updated version of Novavax’s (NASDAQ: NVAX)
FDA Authorizes Novavax (NASDAQ: NVAX) Updated COVID Vaccine Targeting JN.1 Strain Read More »
On Thursday, Novavax (NASDAQ: NVAX) trimmed its annual revenue forecast again and said it would pare back its presence in
Novavax (NASDAQ: NVAX) Slashes 2024 Revenue Guidance Again, To Cut European Presence Read More »
Novavax (NASDAQ: NVAX) stock climbed almost 50% in intraday trading Monday after TD Cowen analyst raised its price target. Brendan
Novavax (NASDAQ: NVAX) Stock Skyrockets as TD Cowen Analyst Lifts Price Target Read More »
Novavax (NASDAQ: NVAX) stock soared almost 100% in intraday trading after signing a COVID-19 license deal with Sanofi and withdrawing
Copyright © 2024 abbonews.com
